DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 -3.91 -0.08%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

VIVUS, Inc. (NASDAQ: VVUS)



company name or ticker

10 Most Hated Companies in Healthcare

When emotional trading is on display, the short-sellers come out to play. Find out which companies are the most hated in healthcare, why they're so universally disliked, and which company may eventually deserve a reprieve.

Orexigen - Contrave Sales Outpace Competition, But Are Still Not Enough

What Novo Nordisk's Entry Into The Obesity Space Means To The Sector

Orexigen Faces Generic Challenge For Anti-Obesity Drug

VIVUS Responds to Teva's Filing for Qsymia Generics - Analyst Blog

3 Promising Healthcare Stocks Under $10

Healthcare stocks with plenty of potential -- and low share prices

Vivus Sales Remain Flat - Stock Trend Not Good

Orexigen: Contrave Scripts Dip - Were My Concerns About Advertising Right?

The Best Stock to Invest in Obesity Drugs

Making money helping people shed the pounds.

Novo Nordisk Quietly Becoming Big Player In Obesity Space

See More Articles...